AtriCure, Inc. — Director's Dealing 2023

Jul 28, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2023-07-26

Reporting Person: Dahlquist Karl S. (Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-26	Common Stock	S	3417	$57.09	Disposed	32037	Direct

Footnotes

F1: These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023.

F2: This transaction was executed in multiple trades at prices ranging from $56.75 to $57.50 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.